XML 78 R57.htm IDEA: XBRL DOCUMENT v3.20.2
INTANGIBLE ASSETS AND GOODWILL - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 20, 2020
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]            
Amortization expense   $ 4,855 $ 25,443 $ 12,650 $ 50,887  
Goodwill   14,147   $ 14,147   $ 0
INDOCIN | Product Rights            
Finite-Lived Intangible Assets [Line Items]            
Useful life (for Other, less than 1 year)       5 years 10 months 24 days    
SPRIX Nasal Spray | Product Rights            
Finite-Lived Intangible Assets [Line Items]            
Useful life (for Other, less than 1 year)       5 years 10 months 24 days    
NUCYNTA | Product Rights            
Finite-Lived Intangible Assets [Line Items]            
Write-off of remaining carrying value, disposition   $ 369,100        
Zyla Life Sciences            
Finite-Lived Intangible Assets [Line Items]            
Goodwill $ 14,147          
Zyla Life Sciences | INDOCIN            
Finite-Lived Intangible Assets [Line Items]            
Acquired finite-lived intangible assets, fair value 107,500          
Zyla Life Sciences | SPRIX Nasal Spray            
Finite-Lived Intangible Assets [Line Items]            
Acquired finite-lived intangible assets, fair value 52,500          
Zyla Life Sciences | Other            
Finite-Lived Intangible Assets [Line Items]            
Acquired finite-lived intangible assets, fair value $ 900          
Zyla Life Sciences | Other | Product Rights            
Finite-Lived Intangible Assets [Line Items]            
Useful life (for Other, less than 1 year) 1 year     1 year